The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...
Q3 2025 Earnings Call November 5, 2025 8:30 AM ESTCompany ParticipantsAlex Giaimo - Head of Investor RelationsMatthew Bromberg ...
Failure by municipal and national governments in any given country to provide adequately for the needs of both small, medium and large business enterprises can significantly reduce the potential of ...
Learn more about whether BioMarin Pharmaceutical Inc. or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ ...
IonQ (NYSE: IONQ), the world's leading quantum company, today announced financial results for the quarter ended September 30, 2025.
Learn more about whether Alkermes plc or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ Investor ...
Ralliant Corporation ( RAL) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Hello. My name is Donna, and I will be your conference facilitator this morning. At this time, I would like to welcome ...
Bookings of $951 million, representing a book-to-bill of 141%Revenues of $2.18 billionNet Income of $42 million, or $0.11 per shareAdjusted ...
During the third quarter of 2025, the company repurchased 2.0 million shares of its common stock through open market transactions for $50.0 million. At September 30, 2025, the company had $200.0 ...
INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...
Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback